GLP-1 receptor agonist therapy for obesity via direct-to-consumer telemedicine: Clinical characteristics and treatment outcomes

This study demonstrates the potential effectiveness and accessibility of DTC telemedicine for obesity treatment using liraglutide, though gastrointestinal side effects were common. The findings support the use of DTC platforms for weight management, yet further research with longer follow-up and professional evaluation is necessary to confirm long-term safety and efficacy.